For the first time, hybrid molecules were synthesized on the basis of lithocholic and (5Z,9Z)-1,14-tetradeca-5,9-dienedicarboxylic acids, obtained in two stages using the homo-cyclomagnesiation reaction of 2-(hepta-5,6-diene-1-yloxy)tetrahydro-2H-pyran at the key stage. The resulting hybrid molecules containing 5Z,9Z-dienoic acids are of interest as novel synthetic biologically active precursors to create modern drugs for the treatment of human oncological diseases. The synthesized hybrid molecules were found to exhibit extremely high in vitro inhibitory activity against human topoisomerase I, which is 2–4 times higher than that of camptothecin, a known topoisomerase I inhibitor. Using flow cytometry and fluorescence microscopy, it was first shown that these new molecules are efficient apoptosis inducers in HeLa, U937, Jurkat, K562, and Hek293 cell cultures. In addition, the results of investigations into the effect of the synthesized acids on mitochondria and studies of possible DNA damage in Jurkat tumor cells are also presented.
首次,基于麻黄酸和(5Z,9Z)-1,14-十四碳-5,9-二烯二
羧酸,在两个阶段使用2-(庚-5,6-二烯-1-氧基)四氢-
2H-吡喃的同环合
镁反应合成了杂化分子。含有5Z,9Z-二烯酸的这些杂化分子作为新型合成
生物活性前体,对于开发治疗人类肿瘤疾病的现代药物具有重要意义。合成的杂化分子显示出极高的体外抑制人类拓扑异构酶I活性,比已知的拓扑异构酶I
抑制剂喜树碱高2-4倍。首次利用流式细胞术和荧光显微镜观察到这些新分子在HeLa、U937、Jurkat、K562和Hek293
细胞培养中是有效的凋亡诱导剂。此外,还介绍了对合成酸对线粒体的影响以及对Jurkat肿瘤细胞可能的DNA损伤研究的结果。